Tucotuzumab celmoleukin

Tucotuzumab celmoleukin
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target EpCAM
Clinical data
ATC code none
CAS Number 339986-90-2 YesY
ChemSpider none
KEGG D09027 YesY
Chemical and physical data
Formula C7812H12124N2044O2408S60
Molar mass 175.1 kg/mol

Tucotuzumab celmoleukin is an anti-cancer drug. It is a fusion protein of a humanized monoclonal antibody (tucotuzumab) and an interleukin-2 (celmoleukin).[1][2][3]

This drug was developed by EMD Pharmaceuticals.


  1. Statement On A Nonproprietary Name Adopted By The Usan Council - Tucotuzumab Celmoleukin, American Medical Association.
  2. ClinicalTrials.gov
  3. National Cancer Institute: Definition of tucotuzumab celmoleukin

This article is issued from Wikipedia - version of the 6/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.